Analysis of two large-scale drug screening data sets (Genomics of Drug Sensitivity in Cancer, Wellcome Sanger Institute, and Massachusetts General Hospital) also identified a highly significant association between the pathognomonic genomic marker in Ewing sarcoma tumors, EWS-FLI, and sensitivity to gemcitabine ( Supplementary Fig.
← all excerpts
Activator Protein-1 (AP-1) Signaling Inhibits the Growth of Ewing Sarcoma Cells in Response to DNA Replication Stress.
1
—
—